Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MOST for Smoking Cessation in HIV Clinical Care
NCT06598397Phase 4Recruiting
- Sponsor
- New York University
- Start
- Oct 2024
- Primary completion
- Jun 2028
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of nicotine in Tobacco Use Disorder (TUD), sponsored by New York University. Started Oct 2024; status: recruiting.
02
Drugs
nicotine
03
Conditions
Tobacco Use Disorder (TUD)
Beyond the preview
Go deeper on NCT06598397.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06598397.